Circulating Tumor Cells for Risk Stratification of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
J. Clin. Oncol 2022 Sep 20;40(27)3151-3161, JJ Garcés, MT Cedena, N Puig, L Burgos, JJ Perez, L Cordon, J Flores-Montero, L Sanoja-Flores, MJ Calasanz, A Ortiol, MJ Blanchard, R Rios, J Martin, R Martínez-Martinez, J Bargay, A Sureda, J de la Rubia, MT Hernandez, P Rodriguez-Otero, J de la Cruz, A Orfao, MV Mateos, J Martinez-Lopez, JJ Lahuerta, L Rosiñol, J Blade, JF San-Miguel, B PaivaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.